Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M N Chang

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Biometrics|March 1, 1989
Confidence intervals for a normal mean following a group sequential testM N Chang
Controlled Clinical Trials|March 1, 1986
Confidence intervals following group sequential testsM N Chang, P C O'Brien
Mathematical Biosciences|March 1, 1990
A stochastic model for analyzing prevalence surveys of hepatitis A antibodyG L Yang, M N Chang
Biometrics|September 1, 1994
Interim analysis for randomized clinical trials: simulating the predictive distribution of the log-rank test statisticM N Chang, J J Shuster
Controlled Clinical Trials|August 10, 1999
Group sequential designs for phase II trials with historical controlsM N Chang, J J Shuster, J L Kepner
Statistics in Medicine|May 1, 1989
The bias of the sample proportion following a group sequential phase II clinical trialM N Chang, H S Wieand, V T Chang
Statistics in Medicine|September 30, 1994
Reduction in burden of illness: a new efficacy measure for prevention trialsM N Chang, H A Guess, J F Heyse
Medical and Pediatric Oncology|August 10, 2001
A phase II study of Homoharringtonine for the treatment of children with refractory or recurrent acute myelogenous leukemia: a pediatric oncology group studyB A Bell, M N Chang, H J Weinstein
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|January 1, 1986
[The investigation of lignans from Sargentodoxa cuneata (Oliv) Rehd et Wils]G Q Han, M N Chang, S B Hwang
The Journal of Biological Chemistry|October 15, 1986
Specific binding of [3H]dihydrokadsurenone to rabbit platelet membranes and its inhibition by the receptor agonists and antagonists of platelet-activating factorS B Hwang, M H Lam, M N Chang
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Biometrics|March 1, 1989
Confidence intervals for a normal mean following a group sequential testM N Chang
Controlled Clinical Trials|March 1, 1986
Confidence intervals following group sequential testsM N Chang, P C O'Brien
Mathematical Biosciences|March 1, 1990
A stochastic model for analyzing prevalence surveys of hepatitis A antibodyG L Yang, M N Chang
Biometrics|September 1, 1994
Interim analysis for randomized clinical trials: simulating the predictive distribution of the log-rank test statisticM N Chang, J J Shuster
Controlled Clinical Trials|August 10, 1999
Group sequential designs for phase II trials with historical controlsM N Chang, J J Shuster, J L Kepner
Statistics in Medicine|May 1, 1989
The bias of the sample proportion following a group sequential phase II clinical trialM N Chang, H S Wieand, V T Chang
Statistics in Medicine|September 30, 1994
Reduction in burden of illness: a new efficacy measure for prevention trialsM N Chang, H A Guess, J F Heyse
Medical and Pediatric Oncology|August 10, 2001
A phase II study of Homoharringtonine for the treatment of children with refractory or recurrent acute myelogenous leukemia: a pediatric oncology group studyB A Bell, M N Chang, H J Weinstein
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|January 1, 1986
[The investigation of lignans from Sargentodoxa cuneata (Oliv) Rehd et Wils]G Q Han, M N Chang, S B Hwang
The Journal of Biological Chemistry|October 15, 1986
Specific binding of [3H]dihydrokadsurenone to rabbit platelet membranes and its inhibition by the receptor agonists and antagonists of platelet-activating factorS B Hwang, M H Lam, M N Chang
Pageof 5